63485-51-8 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
Methyl trans-3-hydroxycyclopentanecarboxylate is used as an intermediate in the production of various chemicals for pharmaceutical and agrochemical applications. Its role in the synthesis of biologically active compounds makes it a valuable component in the development of new drugs and agrochemical products.
Used in Flavor and Fragrance Industry:
Methyl trans-3-hydroxycyc... also has potential applications in the production of flavors, fragrances, and other specialty chemicals. Its unique properties contribute to the creation of distinct scents and tastes in various consumer products.
Used in Organic Synthesis:
Methyl trans-3-hydroxycyclopentanecarboxylate is utilized as a building block in organic synthesis, allowing chemists to create a wide range of chemical compounds with diverse applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 63485-51-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,4,8 and 5 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 63485-51:
(7*6)+(6*3)+(5*4)+(4*8)+(3*5)+(2*5)+(1*1)=138
138 % 10 = 8
So 63485-51-8 is a valid CAS Registry Number.
63485-51-8Relevant articles and documents
OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
-
, (2015/05/19)
This invention pertains generally to treating bacterial infections using organic compounds of Formula I. In certain aspects, the invention pertains to treating infections caused by Gram-negative bacteria. (I) wherein X, Y, R1, R2, R3, R4 and R5 and defined herein.
ORGANIC COMPOUNDS
-
Page/Page column 72-73, (2009/05/28)
The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R5, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
